[HTML][HTML] Comparison of effectiveness and safety of low-dose versus standard-dose intravenous recombinant tissue plasminogen activator in patients with acute …
J Karedath, FNU Avanteeka, MN Aslam, A Nadeem… - Cureus, 2023 - ncbi.nlm.nih.gov
The aim of the present meta-analysis is to compare the efficacy and safety of low-dose and
standard-dose recombinant tissue plasminogen activators (r-tPA) in patients with acute …
standard-dose recombinant tissue plasminogen activators (r-tPA) in patients with acute …
Different Doses of Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: A Network Meta-Analysis
BH Li, JH Wang, H Wang, DZ Wang, S Yang… - Frontiers in …, 2022 - frontiersin.org
Background This study aims to assess the efficacy and safety of different doses of
intravenous tissue-type plasminogen activator (tPA) for acute ischemic stroke (AIS) by …
intravenous tissue-type plasminogen activator (tPA) for acute ischemic stroke (AIS) by …
醒后卒中临床诊治的研究新进展
刘筱翼， 王保爱 - 中国全科医学, 2022 - chinagp.net
醒后卒中(WUS) 是指睡前无新发卒中症状, 在醒后或睡眠过程中出现新发神经系统功能缺损的
急性脑血管病, 症状开始时间未知, 多属缺血性卒中. 近年来, 随着对WUS 发病机制的探究以及 …
急性脑血管病, 症状开始时间未知, 多属缺血性卒中. 近年来, 随着对WUS 发病机制的探究以及 …
Progress in Clinical Diagnosis and Treatment of Wake-up Stroke
LIU Xiaoyi, W Baoai - Chinese General Practice, 2022 - chinagp.net
Wake-up stroke (WUS) refers to acute cerebrovascular disease without new onset stroke
symptoms at bedtime whereas new onset neurological deficits after waking up or during …
symptoms at bedtime whereas new onset neurological deficits after waking up or during …
Climate Change and Health
Z Vujković, G Trbić - ОДРЖИВИ РАЗВОЈ И УПРАВЉАЊЕ …, 2023 - doisrpska.nub.rs
Climate change is becoming an increasing threat and one of the biggest health challenges
facing humanity. A very unfavorable impact on the most important health factors: food, air …
facing humanity. A very unfavorable impact on the most important health factors: food, air …